Kamil Piska

891 total citations
40 papers, 647 citations indexed

About

Kamil Piska is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kamil Piska has authored 40 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Organic Chemistry and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kamil Piska's work include Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Natural product bioactivities and synthesis (4 papers). Kamil Piska is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Natural product bioactivities and synthesis (4 papers). Kamil Piska collaborates with scholars based in Poland, France and Netherlands. Kamil Piska's co-authors include Elżbieta Pękala, Paulina Koczurkiewicz, Katarzyna Wójcik‐Pszczoła, Agnieszka Gunia‐Krzyżak, Adam Bucki, Marcin Kołaczkowski, Bożena Muszyńska, Katarzyna Sułkowska‐Ziaja, Ewa Skrzypczak‐Pietraszek and Jacek Pietraszek and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hazardous Materials and Scientific Reports.

In The Last Decade

Kamil Piska

37 papers receiving 639 citations

Peers

Countries citing papers authored by Kamil Piska

Since Specialization

Citations

This map shows the geographic impact of Kamil Piska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamil Piska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamil Piska more than expected).

Fields of papers citing papers by Kamil Piska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamil Piska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamil Piska. The network helps show where Kamil Piska may publish in the future.

Co-authorship network of co-authors of Kamil Piska

This figure shows the co-authorship network connecting the top 25 collaborators of Kamil Piska. A scholar is included among the top collaborators of Kamil Piska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamil Piska. Kamil Piska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biotransformation of oxybenzone and 3-(4-methylbenzylidene)camphor in Cunninghamella species: Potential for environmental clean-up of widely used sunscreen agents 2025 ·Journal of Hazardous Materials ·(unknown), Justyna Popiół, Agnieszka Gunia‐Krzyżak, Dorota Żelaszczyk, (unknown), Paulina Koczurkiewicz, Kamil Piska, Paweł Żmudzki, Elżbieta Pękala, Karolina Słoczyńska	0
2	Improving Activity of New Arylurea Agents against Multidrug-Resistant and Biofilm-Producing Staphylococcus epidermidis 2024 ·ACS Medicinal Chemistry Letters ·Vittorio Canale, (unknown), (unknown), Monika Papież, (unknown), Bartosz Pomierny, Kamil Piska, Paulina Koczurkiewicz, Joanna Empel, Elżbieta Karczewska, Paweł Zajdel	0
3	Aclarubicin: contemporary insights into its mechanism of action, toxicity, pharmacokinetics, and clinical standing 2024 ·Cancer Chemotherapy and Pharmacology ·(unknown), (unknown), (unknown), Anna Mróz, (unknown), (unknown), (unknown), Paulina Koczurkiewicz, Kamil Piska, Elżbieta Pękala	7
4	In Silico and In Vitro Assessment of Carbonyl Reductase 1 Inhibition Using ASP9521—A Potent Aldo-Keto Reductase 1C3 Inhibitor with the Potential to Support Anticancer Therapy Using Anthracycline Antibiotics 2023 ·Molecules ·(unknown), Kamil Piska, Adam Bucki, Paulina Koczurkiewicz, (unknown), Benedykt Władyka, Elżbieta Pękala, Marcin Kołaczkowski	4
5	Saponin Fraction CIL1 from Lysimachia ciliata L. Enhances the Effect of a Targeted Toxin on Cancer Cells 2023 ·Pharmaceutics ·Paulina Koczurkiewicz, Karolina Grabowska, Elżbieta Karnas, Kamil Piska, Dawid Wnuk, (unknown), Agnieszka Galanty, Katarzyna Wójcik‐Pszczoła, Marta Michalik, Elżbieta Pękala, Hendrik Fuchs, Irma Podolak	2
6	Comparative study on ABCB1-dependent efflux of anthracyclines and their metabolites: consequences for cancer resistance 2023 ·Xenobiotica ·Kamil Piska, Paulina Koczurkiewicz, (unknown), Adam Bucki, Marcin Kołaczkowski, Elżbieta Pękala	0
7	Design and synthesis of novel arylurea derivatives of aryloxy(1-phenylpropyl) alicyclic diamines with antimicrobial activity against multidrug-resistant Gram-positive bacteria 2023 ·European Journal of Medicinal Chemistry ·Vittorio Canale, (unknown), (unknown), Monika Papież, (unknown), (unknown), Kamil Piska, (unknown), (unknown), Elżbieta Pękala, Joanna Empel, (unknown), Elżbieta Karczewska, Paweł Zajdel	4
8	Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin 2021 ·International Journal of Molecular Sciences ·Paulina Koczurkiewicz, (unknown), Agnieszka Gunia‐Krzyżak, Kamil Piska, (unknown), Jacek Stępniewski, Sławomir Lasota, Katarzyna Wójcik‐Pszczoła, Józef Dulak, Zbigniew Madeja, Elżbieta Pękala	18
9	Carbonyl reduction pathway in hepatic in vitro metabolism of anthracyclines: Impact of structure on biotransformation rate 2021 ·Toxicology Letters ·Kamil Piska, (unknown), Paulina Koczurkiewicz, Adam Bucki, Paweł Żmudzki, Marcin Kołaczkowski, Elżbieta Pękala	6
10	Cinnamic acid derivatives as chemosensitising agents against DOX-treated lung cancer cells – Involvement of carbonyl reductase 1 2020 ·European Journal of Pharmaceutical Sciences ·Paulina Koczurkiewicz, Kamil Piska, Agnieszka Gunia‐Krzyżak, Adam Bucki, (unknown), (unknown), Damian Ryszawy, Katarzyna Wójcik‐Pszczoła, Marta Michalik, Henryk Marona, Marcin Kołaczkowski, Elżbieta Pękala	18
11	Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer 2020 ·Investigational New Drugs ·(unknown), Paulina Koczurkiewicz, Kamil Piska, Elżbieta Pękala	49
12	The Involvement of Xanthone and (E)-Cinnamoyl Chromophores for the Design and Synthesis of Novel Sunscreening Agents 2020 ·International Journal of Molecular Sciences ·Justyna Popiół, Agnieszka Gunia‐Krzyżak, Karolina Słoczyńska, Paulina Koczurkiewicz, Kamil Piska, Katarzyna Wójcik‐Pszczoła, Dorota Żelaszczyk, Anna Krupa, Paweł Żmudzki, Henryk Marona, Elżbieta Pękala	11
13	A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties 2020 ·European Journal of Medicinal Chemistry ·Vittorio Canale, Katarzyna Grychowska, Rafał Kurczab, (unknown), (unknown), (unknown), Agnieszka Olejarz‐Maciej, Paulina Koczurkiewicz, (unknown), (unknown), Kamil Piska, Elżbieta Pękala, (unknown), Martyna Krawczyk, Maria Walczak, Séverine Chaumont‐Dubel, Andrzej J. Bojarski, Philippe Marin, Piotr Popik, Paweł Zajdel	18
14	Discovery of Novel UV-Filters with Favorable Safety Profiles in the 5-Arylideneimidazolidine-2,4-dione Derivatives Group 2019 ·Molecules ·Justyna Popiół, Agnieszka Gunia‐Krzyżak, Kamil Piska, Dorota Żelaszczyk, Paulina Koczurkiewicz, Karolina Słoczyńska, Katarzyna Wójcik‐Pszczoła, Anna Krupa, Agata Kryczyk‐Poprawa, Ewa Żesławska, Wojciech Nitek, Paweł Żmudzki, Henryk Marona, Elżbieta Pękala	10
15	Saponins as chemosensitizing substances that improve effectiveness and selectivity of anticancer drug—Minireview of in vitro studies 2019 ·Phytotherapy Research ·Paulina Koczurkiewicz, (unknown), Karolina Grabowska, Kamil Piska, (unknown), Katarzyna Wójcik‐Pszczoła, Irma Podolak, Agnieszka Galanty, Marta Michalik, Elżbieta Pękala	25
16	Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells – The involvement of carbonyl reductase 1 inhibition 2019 ·Chemico-Biological Interactions ·Kamil Piska, Paulina Koczurkiewicz, Dawid Wnuk, Elżbieta Karnas, Adam Bucki, Katarzyna Wójcik‐Pszczoła, (unknown), Marta Michalik, Marcin Kołaczkowski, Elżbieta Pękala	31
17	Microbial biotransformation of some novel hydantoin derivatives: Perspectives for bioremediation of potential sunscreen agents 2019 ·Chemosphere ·Justyna Popiół, Kamil Piska, Karolina Słoczyńska, (unknown), Dorota Żelaszczyk, Agnieszka Gunia‐Krzyżak, Paulina Koczurkiewicz, Katarzyna Wójcik‐Pszczoła, Henryk Marona, Elżbieta Pękala	6
18	Usnic acid reactive metabolites formation in human, rat, and mice microsomes. Implication for hepatotoxicity 2018 ·Food and Chemical Toxicology ·Kamil Piska, Agnieszka Galanty, Paulina Koczurkiewicz, Paweł Żmudzki, (unknown), Irma Podolak, Elżbieta Pękala	21
19	Edible mushroom Pleurotus ostreatus (oyster mushroom) - its dietary significance and biological activity. 2017 ·Acta Scientiarum Polonorum Hortorum Cultus ·Kamil Piska, Katarzyna Sułkowska‐Ziaja, Bożena Muszyńska	33
20	Metabolic carbonyl reduction of anthracyclines — role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents 2017 ·Investigational New Drugs ·Kamil Piska, Paulina Koczurkiewicz, Adam Bucki, Katarzyna Wójcik‐Pszczoła, Marcin Kołaczkowski, Elżbieta Pękala	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact